References
1. Dubois, C., et al., Multidisciplinary work in oncology:
Population-based analysis for seven invasive tumours. Eur J Cancer Care
(Engl), 2018. 27 (2): p. e12822.
2. Serruys, P.W., et al., Percutaneous coronary intervention
versus coronary-artery bypass grafting for severe coronary artery
disease. N Engl J Med, 2009. 360 (10): p. 961-72.
3. Girasis, C., et al., SYNTAX score and Clinical SYNTAX score as
predictors of very long-term clinical outcomes in patients undergoing
percutaneous coronary interventions: a substudy of SIRolimus-eluting
stent compared with pacliTAXel-eluting stent for coronary
revascularization (SIRTAX) trial. Eur Heart J, 2011. 32 (24):
p. 3115-27.
4. Kappetein, A.P., et al., Current percutaneous coronary
intervention and coronary artery bypass grafting practices for
three-vessel and left main coronary artery disease. Insights from the
SYNTAX run-in phase. Eur J Cardiothorac Surg, 2006. 29 (4): p.
486-91.
5. Head, S.J., et al., The rationale for Heart Team
decision-making for patients with stable, complex coronary artery
disease. Eur Heart J, 2013. 34 (32): p. 2510-8.
6. Neumann, F.J., et al., [2018 ESC/EACTS Guidelines on
myocardial revascularization. The Task Force on myocardial
revascularization of the European Society of Cardiology (ESC) and
European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital
Cardiol (Rome), 2019. 20 (7-8 Suppl 1): p. 1S-61S.
7. Shahian, D.M., et al., The Society of Thoracic Surgeons 2008
cardiac surgery risk models: part 1–coronary artery bypass grafting
surgery. Ann Thorac Surg, 2009. 88 (1 Suppl): p. S2-22.
8. Rui, A., et al., Are the guidelines for coronary artery
revascularization, according to the syntax score, being correctly
applied, by a heart team? 2015, Journal of Cardiothoracic Surgery. p. A
183.
9. Domingues, C.T., et al., Heart Team decision making and
long-term outcomes for 1000 consecutive cases of coronary artery
disease. Interact Cardiovasc Thorac Surg, 2019. 28 (2): p.
206-213.
10. Patel, M.R., et al., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016
Appropriate Use Criteria for Coronary Revascularization in Patients With
Acute Coronary Syndromes: A Report of the American College of Cardiology
Appropriate Use Criteria Task Force, American Association for Thoracic
Surgery, American Heart Association, American Society of
Echocardiography, American Society of Nuclear Cardiology, Society for
Cardiovascular Angiography and Interventions, Society of Cardiovascular
Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll
Cardiol, 2017. 69 (5): p. 570-591.
11. Mohr, F.W., et al., Coronary artery bypass graft surgery
versus percutaneous coronary intervention in patients with three-vessel
disease and left main coronary disease: 5-year follow-up of the
randomised, clinical SYNTAX trial. Lancet, 2013. 381 (9867): p.
629-38.
12. Boudriot, E., et al., Randomized comparison of percutaneous
coronary intervention with sirolimus-eluting stents versus coronary
artery bypass grafting in unprotected left main stem stenosis. J Am
Coll Cardiol, 2011. 57 (5): p. 538-45.
13. Park, S.J., et al., Randomized trial of stents versus bypass
surgery for left main coronary artery disease. N Engl J Med, 2011.364 (18): p. 1718-27.
14. Park, S.J., et al., Trial of everolimus-eluting stents or
bypass surgery for coronary disease. N Engl J Med, 2015.372 (13): p. 1204-12.
15. Mäkikallio, T., et al., Percutaneous coronary angioplasty
versus coronary artery bypass grafting in treatment of unprotected left
main stenosis (NOBLE): a prospective, randomised, open-label,
non-inferiority trial. Lancet, 2016. 388 (10061): p. 2743-2752.
16. Head, S.J., et al., Mortality after coronary artery bypass
grafting versus percutaneous coronary intervention with stenting for
coronary artery disease: a pooled analysis of individual patient data.Lancet, 2018. 391 (10124): p. 939-948.
17. Holmes, D.R., et al., The heart team of cardiovascular care.J Am Coll Cardiol, 2013. 61 (9): p. 903-7.
18. Farkouh, M.E., et al., Strategies for multivessel
revascularization in patients with diabetes. N Engl J Med, 2012.367 (25): p. 2375-84.
19. Abdulrahman, M., et al., Impact of Hierarchy on
Multidisciplinary Heart-Team Recommendations in Patients with Isolated
Multivessel Coronary Artery Disease. J Clin Med, 2019. 8 (9).
20. Bonzel, T., V. Schächinger, and H. Dörge, Description of a
Heart Team approach to coronary revascularization and its beneficial
long-term effect on clinical events after PCI. Clin Res Cardiol, 2016.105 (5): p. 388-400.
21. Sanchez, C.E., et al., Revascularization heart team
recommendations as an adjunct to appropriate use criteria for coronary
revascularization in patients with complex coronary artery disease.Catheter Cardiovasc Interv, 2016. 88 (4): p. E103-E112.
22. Damman, P., et al., 2015 ESC guidelines for the management of
acute coronary syndromes in patients presenting without persistent
ST-segment elevation: comments from the Dutch ACS working group. Neth
Heart J, 2017. 25 (3): p. 181-185.